A detailed history of Probity Advisors, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Probity Advisors, Inc. holds 3,516 shares of ABT stock, worth $407,504. This represents 0.08% of its overall portfolio holdings.

Number of Shares
3,516
Previous 3,601 2.36%
Holding current value
$407,504
Previous $374,000 6.95%
% of portfolio
0.08%
Previous 0.08%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$100.07 - $118.13 $8,505 - $10,041
-85 Reduced 2.36%
3,516 $400,000
Q2 2024

Aug 14, 2024

SELL
$100.73 - $112.44 $402 - $449
-4 Reduced 0.11%
3,601 $374,000
Q1 2024

May 02, 2024

SELL
$109.52 - $120.96 $10,294 - $11,370
-94 Reduced 2.54%
3,605 $409,000
Q4 2023

Feb 12, 2024

SELL
$90.19 - $110.4 $23,539 - $28,814
-261 Reduced 6.59%
3,699 $407,000
Q3 2023

Nov 14, 2023

BUY
$95.53 - $114.62 $3,056 - $3,667
32 Added 0.81%
3,960 $383,000
Q2 2023

Aug 10, 2023

SELL
$100.78 - $112.29 $21,667 - $24,142
-215 Reduced 5.19%
3,928 $428,000
Q4 2022

Feb 14, 2023

SELL
$95.06 - $111.52 $9,220 - $10,817
-97 Reduced 2.29%
4,143 $454,000
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $9,192 - $10,642
-95 Reduced 2.19%
4,240 $410,000
Q2 2022

Aug 12, 2022

SELL
$102.07 - $123.37 $22,863 - $27,634
-224 Reduced 4.91%
4,335 $471,000
Q1 2022

May 10, 2022

SELL
$114.02 - $139.04 $8,665 - $10,567
-76 Reduced 1.64%
4,559 $540,000
Q4 2021

Feb 10, 2022

SELL
$115.53 - $141.46 $32,348 - $39,608
-280 Reduced 5.7%
4,635 $652,000
Q3 2021

Oct 08, 2021

SELL
$116.66 - $129.06 $12,715 - $14,067
-109 Reduced 2.17%
4,915 $581,000
Q2 2021

Aug 06, 2021

SELL
$105.79 - $124.53 $29,621 - $34,868
-280 Reduced 5.28%
5,024 $582,000
Q1 2021

Apr 28, 2021

SELL
$108.84 - $128.23 $31,563 - $37,186
-290 Reduced 5.18%
5,304 $636,000
Q3 2020

Nov 09, 2020

SELL
$91.64 - $111.29 $37,205 - $45,183
-406 Reduced 6.77%
5,594 $609,000
Q2 2020

Aug 03, 2020

SELL
$76.57 - $98.0 $27,871 - $35,672
-364 Reduced 5.72%
6,000 $549,000
Q1 2020

May 15, 2020

SELL
$62.82 - $91.86 $46,423 - $67,884
-739 Reduced 10.4%
6,364 $502,000
Q4 2019

Feb 13, 2020

SELL
$78.51 - $87.4 $23,631 - $26,307
-301 Reduced 4.07%
7,103 $617,000
Q3 2019

Nov 14, 2019

BUY
$81.84 - $88.74 $33,554 - $36,383
410 Added 5.86%
7,404 $619,000
Q2 2019

Aug 08, 2019

SELL
$72.88 - $85.0 $36,658 - $42,755
-503 Reduced 6.71%
6,994 $588,000
Q1 2019

Apr 29, 2019

SELL
$66.22 - $80.06 $46,486 - $56,202
-702 Reduced 8.56%
7,497 $599,000
Q4 2018

Feb 12, 2019

SELL
$65.56 - $74.27 $48,186 - $54,588
-735 Reduced 8.23%
8,199 $593,000
Q3 2018

Nov 14, 2018

SELL
$60.81 - $73.36 $7,418 - $8,949
-122 Reduced 1.35%
8,934 $655,000
Q2 2018

Aug 13, 2018

SELL
$57.57 - $63.54 $21,300 - $23,509
-370 Reduced 3.93%
9,056 $552,000
Q1 2018

Apr 16, 2018

SELL
$56.27 - $63.62 $110,064 - $124,440
-1,956 Reduced 17.19%
9,426 $565,000
Q4 2017

Feb 09, 2018

SELL
$53.68 - $57.47 $74,078 - $79,308
-1,380 Reduced 10.81%
11,382 $650,000
Q3 2017

Oct 27, 2017

BUY
$48.06 - $53.64 $613,341 - $684,553
12,762
12,762 $681,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Probity Advisors, Inc. Portfolio

Follow Probity Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Probity Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Probity Advisors, Inc. with notifications on news.